HBV, HCV

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections account for a substantial proportion of liver diseases worldwide. The two viruses share same modes of transmission, coinfection is not uncommon, especially among high risk populations.


Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis

There are concerns around poorer response to direct-acting antiviral (DAA) therapy for hepatitis C virus infection among people who use drugs. This systematic review assessed DAA treatment outcomes among people with recent drug use and those receiving opioid substitution therapy.

Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis Website, English

Talking About Hepatitis C: FAQs From Young Adults Who Inject Drugs

Peer-supported and strongly integrated, comprehensive HCV care will help PWID reach high uptake and adherence to c

Talking About Hepatitis C: FAQs From Young Adults Who Inject Drugs Website, English

Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia. Tamar Kikvidze et al.

Peer support can enable patient engagement with healthcare services, particularly for marginalised populations. In this randomised controlled trial, the efficacy of a peer support intervention at promoting successful engagement with clinical services for chronic hepatitis C was assessed.

Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia. Tamar Kikvidze et al. Website, English

Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients. Carriere MP et al.

Coffee has anti-inflammatory and hepatoprotective properties. In the general population, drinking ≥3 cups of coffee/day has been associated with a 14% reduction in the risk of all-cause mortality. The aim of this study was to investigate the relationship between coffee consumption and the risk of allcause mortality in patients co-infected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV). Methods: ANRS CO13 HEPAVIH is an ongoing Fre

Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients. Carriere MP et al. Website, English

Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support intervention, R. Stagg et. al.

Peer support can enable patient engagement with healthcare services, particularly for marginalised populations. In this randomised controlled trial, the efficacy of a peer support intervention at promoting successful engagement with clinical services for chronic hepatitis C was assessed.

Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support intervention, R. Stagg et. al. Website, English

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Larney, et. Al

Coverage of HIV and HCV prevention interventions for PWID remains poor and is likely to be insufficient to effectively prevent HIV and HCV transmission. Scaling up of interventions for PWID remains a crucial priority for halting the HIV and HCV epidemics.

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Larney, et. Al Website, English

Understanding and Addressing Hepatitis C Virus Reinfection Among Men Who Have Sex with Men, Martin et al

Behavioral interventions studies addressing hepatitis C virus reinfection are required, such as the ongoing HCVree trial in Switzerland. Other interventions may include traditional harm reduction interventions, adapted behavioral interventions, and interventions to prevent risk related to substance use with sex.

Understanding and Addressing Hepatitis C Virus Reinfection Among Men Who Have Sex with Men, Martin et al Website, English

Training Manual for Treatment Advocates; Hepatitis C Virus & coinfection with HIV, Annette Gaudino, Bryn Gay, and Tim Horn

A primary goal of the Training Manual is to increase advocates’ knowledge about available HCV tests and treatments and to jumpstart discussions on advocacy strategies that can be used to open up affordable access for more people with HCV.

Training Manual for Treatment Advocates; Hepatitis C Virus & coinfection with HIV, Annette Gaudino, Bryn Gay, and Tim Horn Website, English

Liver or Die: HCV Training for Peer Workers

HCV capacity building training for harm reduction programs and peer workers

Liver or Die: HCV Training for Peer Workers Website, English

Hepatitis B and C testing: Why? Who? How?

This paper aims to stimulate services to engage in HCV and HBV awareness raising and in particular to inform community members, social and health care practitioners about current HBV/HCV testing and diagnosis methods, screening technologies and other aspects around the issue.

Hepatitis B and C testing: Why? Who? How? PDF, English

In partnership with:
ISFF
FUAS
Correlation Network